THBS4 is part of the extracellular matrix, and its regulation of HCC progression is related to the interaction of Integrin β1, which involves the FAK/PI3K/AKT signaling pathway [39] and may be a prognostic marker or potential therapeutic target for HCC [40]. The gene discussed is PTK2; the disease is hepatocellular carcinoma.